ALBUTEROL SULFATE

ALBUTEROL SULFATE was reported 299876 times

ALBUTEROL SULFATE is most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 DEVICE DEPOSIT ISSUE 1884 0.9253
1 WRONG TECHNIQUE IN PRODUCT USAGE PROCESS PERFORMED IN ERROR 485 0.7886
2 PRODUCT CLEANING INADEQUATE 2084 0.7808
3 APPENDICOLITH 275 0.7106
4 SPIROMETRY ABNORMAL 351 0.5870
5 ASTHMA-CHRONIC OBSTRUCTIVE PULMONARY DISEASE OVERLAP SYNDROME 303 0.5793
6 REVERSIBLE AIRWAYS OBSTRUCTION 292 0.5748
7 INHALATION THERAPY 360 0.5714
8 MITE ALLERGY 368 0.5618
9 BRONCHOPULMONARY ASPERGILLOSIS ALLERGIC 469 0.5059
10 DUST ALLERGY 481 0.4903
11 FORCED EXPIRATORY VOLUME DECREASED 1333 0.4700
12 PULMONARY VASCULITIS 244 0.4535
13 BRONCHIAL WALL THICKENING 299 0.4159
14 DEVICE DELIVERY SYSTEM ISSUE 11365 0.4147
15 MYCOTIC ALLERGY 341 0.3988
16 EJECTION FRACTION 209 0.3597
17 OBSTRUCTIVE AIRWAYS DISORDER 3942 0.3540
18 SENSITISATION 266 0.3505
19 BRONCHIAL SECRETION RETENTION 427 0.3352
20 FULL BLOOD COUNT ABNORMAL 3474 0.3281
21 FORCED VITAL CAPACITY DECREASED 214 0.3277
22 PULMONARY FUNCTION TEST ABNORMAL 509 0.3265
23 INCREASED BRONCHIAL SECRETION 777 0.3035
24 BLOOD IMMUNOGLOBULIN E INCREASED 735 0.3032
25 SLEEP DISORDER DUE TO A GENERAL MEDICAL CONDITION 4697 0.2763
26 CONJUNCTIVITIS ALLERGIC 398 0.2686
27 ALLERGY TO ANIMAL 279 0.2617
28 LUNG HYPERINFLATION 223 0.2593
29 DEVICE INEFFECTIVE 266 0.2486
30 TOTAL LUNG CAPACITY DECREASED 397 0.2484
31 EOSINOPHILIC GRANULOMATOSIS WITH POLYANGIITIS 502 0.2460
32 SPUTUM DISCOLOURED 2258 0.2378
33 CIRCUMSTANCE OR INFORMATION CAPABLE OF LEADING TO DEVICE USE ERROR 561 0.2361
34 RESPIRATORY SYMPTOM 669 0.2350
35 WHEEZING 13935 0.2348
36 OBSTRUCTIVE SLEEP APNOEA SYNDROME 340 0.2330
37 RHINITIS ALLERGIC 1031 0.2314
38 NASAL POLYPS 1108 0.2248
39 ASTHMA 25267 0.2233
40 BREATH SOUNDS ABNORMAL 1054 0.2135
41 LUPUS VULGARIS 266 0.2111
42 BRONCHIECTASIS 1409 0.2089
43 BRONCHIAL HYPERREACTIVITY 248 0.2062
44 POLYCYSTIC OVARIES 310 0.1997
45 RHONCHI 268 0.1939
46 RESTRICTIVE PULMONARY DISEASE 221 0.1886
47 SPUTUM INCREASED 403 0.1861
48 TEMPERATURE REGULATION DISORDER 413 0.1852
49 INFECTIVE PULMONARY EXACERBATION OF CYSTIC FIBROSIS 966 0.1773
50 BRONCHIAL OBSTRUCTION 248 0.1765
51 NEURITIS 261 0.1689
52 LOWER RESPIRATORY TRACT CONGESTION 271 0.1592
53 RALES 920 0.1583
54 CHRONIC SINUSITIS 594 0.1581
55 DEVICE USE ERROR 5485 0.1577
56 NASAL DISCHARGE DISCOLOURATION 211 0.1529
57 ADJUSTMENT DISORDER WITH DEPRESSED MOOD 315 0.1519
58 PULMONARY FUNCTION TEST DECREASED 661 0.1508
59 CHEST X-RAY ABNORMAL 456 0.1486
60 CYSTIC FIBROSIS 806 0.1454
61 PRODUCTIVE COUGH 6885 0.1441
62 SEDATION COMPLICATION 363 0.1421
63 CHRONIC OBSTRUCTIVE PULMONARY DISEASE 7424 0.1421
64 X-RAY ABNORMAL 250 0.1397
65 ASTHMATIC CRISIS 510 0.1395
66 WRONG TECHNIQUE IN DEVICE USAGE PROCESS 6431 0.1375
67 LUNG OPACITY 354 0.1342
68 UPPER-AIRWAY COUGH SYNDROME 1103 0.1337
69 DEEP VEIN THROMBOSIS POSTOPERATIVE 262 0.1308
70 DRUG DOSE OMISSION BY DEVICE 10233 0.1305
71 RETINITIS 225 0.1301
72 SINUS PAIN 299 0.1281
73 INFUSION SITE DISCHARGE 221 0.1259
74 EOSINOPHIL COUNT INCREASED 1046 0.1254
75 DISLOCATION OF VERTEBRA 281 0.1231
76 LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES 5850 0.1217
77 ESSENTIAL HYPERTENSION 219 0.1195
78 DYSPNOEA EXERTIONAL 4366 0.1158
79 PRODUCT COMPLAINT 2912 0.1148
80 NEPHROGENIC ANAEMIA 530 0.1143
81 FOOD ALLERGY 882 0.1142
82 HYPOVENTILATION 370 0.1134
83 MULTIPLE ALLERGIES 889 0.1133
84 PULMONARY CONGESTION 1480 0.1121
85 SEASONAL ALLERGY 1560 0.1101
86 HYPERPARATHYROIDISM SECONDARY 276 0.1100
87 NASAL OBSTRUCTION 203 0.1082
88 HYPERPHOSPHATAEMIA 229 0.1064
89 EMPHYSEMA 1072 0.1062
90 SECRETION DISCHARGE 1309 0.1044
91 NORMOCHROMIC NORMOCYTIC ANAEMIA 310 0.1031
92 PRODUCT DELIVERY MECHANISM ISSUE 553 0.1027
93 BLOOD PHOSPHORUS INCREASED 278 0.1017
94 PLEURITIC PAIN 280 0.1013
95 SENSITIVITY TO WEATHER CHANGE 530 0.1006
96 THERAPEUTIC PRODUCT INEFFECTIVE 385 0.0995
97 CREATININE RENAL CLEARANCE DECREASED 398 0.0994
98 INFUSION SITE BRUISING 214 0.0990
99 THROAT CLEARING 366 0.0975
100 PRODUCT LOT NUMBER ISSUE 213 0.0959
101 WRONG TECHNIQUE IN PRODUCT USAGE PROCESS 19096 0.0941
102 INFUSION SITE HAEMORRHAGE 308 0.0935
103 PULMONARY PAIN 269 0.0921
104 EAR PRURITUS 315 0.0897
105 MIDDLE INSOMNIA 1673 0.0895
106 RESPIRATION ABNORMAL 617 0.0894
107 RESPIRATORY TRACT CONGESTION 1410 0.0887
108 SLEEP APNOEA SYNDROME 1689 0.0884
109 OXYGEN SATURATION ABNORMAL 250 0.0880
110 INTENTIONAL DEVICE MISUSE 385 0.0872
111 LOWER RESPIRATORY TRACT INFECTION 3933 0.0864
112 RESPIRATORY RATE INCREASED 762 0.0857
113 BRONCHOSPASM 1218 0.0853
114 RHINOVIRUS INFECTION 328 0.0842
115 BURSITIS 1022 0.0841
116 PARANASAL SINUS DISCOMFORT 316 0.0834
117 BRONCHITIS CHRONIC 203 0.0831
118 REBOUND ACID HYPERSECRETION 249 0.0822
119 INFUSION SITE PRURITUS 259 0.0820
120 INCREASED UPPER AIRWAY SECRETION 419 0.0815
121 BLOOD PRESSURE DIASTOLIC ABNORMAL 207 0.0813
122 OBSTRUCTION 323 0.0808
123 IMPAIRED QUALITY OF LIFE 1161 0.0807
124 BRAIN NATRIURETIC PEPTIDE INCREASED 246 0.0797
125 SLEEP TERROR 335 0.0795
126 THERAPEUTIC PRODUCT EFFECT INCOMPLETE 5642 0.0792
127 BENIGN PROSTATIC HYPERPLASIA 409 0.0791
128 DIASTOLIC DYSFUNCTION 244 0.0790
129 BRONCHITIS 5848 0.0789
130 CREPITATIONS 235 0.0788
131 DRUG TOLERANCE DECREASED 221 0.0786
132 INFUSION SITE SWELLING 495 0.0786
133 BONE EROSION 277 0.0782
134 RESPIRATORY DISORDER 2316 0.0773
135 ATELECTASIS 745 0.0770
136 PULMONARY MASS 1147 0.0769
137 DYSPNOEA 43581 0.0769
138 DYSPNOEA AT REST 223 0.0769
139 EAR PAIN 1467 0.0754
140 CHEST DISCOMFORT 7678 0.0749
141 HYPERCAPNIA 224 0.0743
142 COUGH 20850 0.0743
143 RHINITIS 586 0.0726
144 FACET JOINT SYNDROME 236 0.0724
145 ARTERIOSCLEROSIS CORONARY ARTERY 480 0.0724
146 UPPER RESPIRATORY TRACT INFECTION 3322 0.0718
147 SNORING 269 0.0711
148 RESPIRATORY TRACT INFECTION 1844 0.0707
149 PERIPHERAL VENOUS DISEASE 286 0.0700
150 BLOOD PRESSURE SYSTOLIC INCREASED 1357 0.0695
151 LUNG DISORDER 3352 0.0683
152 FOETAL DEATH 354 0.0682
153 OXYGEN SATURATION DECREASED 3828 0.0680
154 HAEMOPTYSIS 1891 0.0677
155 BLOOD TEST ABNORMAL 945 0.0672
156 INFUSION SITE ERYTHEMA 565 0.0670
157 IRON DEFICIENCY 297 0.0660
158 AORTIC STENOSIS 229 0.0657
159 PULMONARY FIBROSIS 1260 0.0656
160 SINUS CONGESTION 880 0.0651
161 SINUS DISORDER 1282 0.0647
162 CANDIDIASIS 259 0.0645
163 NASAL CONGESTION 3762 0.0640
164 DYSPHONIA 3740 0.0639
165 VASCULITIS 740 0.0635
166 INCORRECT DOSE ADMINISTERED BY DEVICE 1663 0.0634
167 INFUSION SITE PAIN 815 0.0632
168 BODY TEMPERATURE DECREASED 622 0.0631
169 OBESITY 1001 0.0628
170 EXERCISE TOLERANCE DECREASED 356 0.0618
171 HYPERCHOLESTEROLAEMIA 586 0.0606
172 RESPIRATORY SYNCYTIAL VIRUS INFECTION 525 0.0602
173 CHOKING SENSATION 331 0.0600
174 POOR QUALITY DEVICE USED 602 0.0599
175 EXOSTOSIS 547 0.0598
176 APHONIA 832 0.0596
177 SARCOIDOSIS 282 0.0593
178 HYPOXIA 2072 0.0588
179 PRESCRIPTION DRUG USED WITHOUT A PRESCRIPTION 361 0.0584
180 BLOOD LACTIC ACID INCREASED 307 0.0582
181 SINUSITIS 5966 0.0582
182 EOSINOPHILIA 1017 0.0580
183 RED CELL DISTRIBUTION WIDTH INCREASED 240 0.0577
184 END STAGE RENAL DISEASE 1049 0.0575
185 C-REACTIVE PROTEIN ABNORMAL 368 0.0573
186 LUNG INFECTION 881 0.0566
187 ARTERIOSCLEROSIS 526 0.0558
188 SLEEP DISORDER DUE TO GENERAL MEDICAL CONDITION, INSOMNIA TYPE 361 0.0555
189 ACUTE RESPIRATORY FAILURE 1064 0.0553
190 IMMUNODEFICIENCY 824 0.0552
191 CARDIAC MURMUR 473 0.0546
192 MATERNAL EXPOSURE TIMING UNSPECIFIED 205 0.0545
193 BODY TEMPERATURE INCREASED 1109 0.0543
194 PSEUDOMONAS INFECTION 466 0.0543
195 DEVICE MECHANICAL ISSUE 742 0.0541
196 ORAL CANDIDIASIS 712 0.0540
197 HYPERVOLAEMIA 267 0.0540
198 FIBROMYALGIA 1301 0.0535
199 PNEUMONIA 17093 0.0527
200 CHOLECYSTITIS CHRONIC 352 0.0525
201 PRODUCT ADMINISTRATION INTERRUPTED 412 0.0524
202 NO ADVERSE EVENT 9433 0.0520
203 HYPERLIPIDAEMIA 622 0.0520
204 BLOOD CALCIUM DECREASED 584 0.0519
205 GASTROOESOPHAGEAL REFLUX DISEASE 4159 0.0516
206 NEUROLOGICAL SYMPTOM 295 0.0516
207 POLYP 337 0.0514
208 PRE-EXISTING CONDITION IMPROVED 314 0.0502
209 RHEUMATIC FEVER 224 0.0502
210 ASPIRATION 550 0.0502
211 INTERVERTEBRAL DISC DEGENERATION 460 0.0497
212 MUSCLE SPASTICITY 609 0.0495
213 FOLLICULITIS 519 0.0494
214 HIATUS HERNIA 637 0.0491
215 THROAT IRRITATION 2191 0.0488
216 EAR INFECTION 1296 0.0487
217 RHINORRHOEA 3146 0.0486
218 SKIN LACERATION 528 0.0485
219 PULMONARY ALVEOLAR HAEMORRHAGE 272 0.0484
220 PNEUMOTHORAX 768 0.0484
221 DECREASED ACTIVITY 522 0.0483
222 SNEEZING 1083 0.0482
223 LYMPHOEDEMA 332 0.0480
224 HYPERVENTILATION 278 0.0479
225 COELIAC DISEASE 470 0.0479
226 AUTOIMMUNE DISORDER 467 0.0479
227 BREAST CANCER STAGE III 309 0.0477
228 PHARYNGEAL SWELLING 463 0.0473
229 DEVICE OCCLUSION 664 0.0471
230 CHOKING 920 0.0471
231 TRICUSPID VALVE INCOMPETENCE 374 0.0470
232 CARPAL TUNNEL SYNDROME 659 0.0470
233 DEVICE INFORMATION OUTPUT ISSUE 365 0.0468
234 SCOLIOSIS 290 0.0468
235 RESPIRATORY DISTRESS 1290 0.0467
236 CANDIDA INFECTION 783 0.0463
237 HYPOPHOSPHATAEMIA 340 0.0460
238 SPINAL OSTEOARTHRITIS 403 0.0458
239 OROPHARYNGEAL PAIN 4222 0.0456
240 DEVICE MALFUNCTION 3203 0.0455
241 VIRAL INFECTION 1504 0.0452
242 PRESCRIBED OVERDOSE 873 0.0451
243 PNEUMONIA BACTERIAL 414 0.0451
244 PHARMACEUTICAL PRODUCT COMPLAINT 1167 0.0449
245 BLOOD COUNT ABNORMAL 678 0.0447
246 BLOOD PRESSURE DIASTOLIC DECREASED 330 0.0447
247 DRY THROAT 453 0.0445
248 DUODENAL ULCER PERFORATION 331 0.0445
249 GRIP STRENGTH DECREASED 391 0.0444
250 WOUND INFECTION 485 0.0442
251 BLOOD URIC ACID INCREASED 254 0.0439
252 ANTI-CYCLIC CITRULLINATED PEPTIDE ANTIBODY POSITIVE 315 0.0439
253 BLOOD CALCIUM INCREASED 384 0.0437
254 CHRONIC KIDNEY DISEASE 3322 0.0437
255 RIB FRACTURE 896 0.0435
256 VIRAL UPPER RESPIRATORY TRACT INFECTION 207 0.0435
257 INFLUENZA 4816 0.0431
258 POST-TRAUMATIC STRESS DISORDER 289 0.0431
259 RHEUMATOID FACTOR POSITIVE 249 0.0431
260 BLOOD IRON DECREASED 511 0.0430
261 OROPHARYNGEAL DISCOMFORT 388 0.0429
262 HEART RATE INCREASED 4239 0.0427
263 SKIN ABRASION 202 0.0427
264 MUSCLE INJURY 354 0.0427
265 DRUG DELIVERY SYSTEM MALFUNCTION 218 0.0426
266 PRODUCT QUALITY ISSUE 5778 0.0425
267 ACTIVATED PARTIAL THROMBOPLASTIN TIME PROLONGED 215 0.0424
268 APPENDICITIS 395 0.0422
269 CARDIOMEGALY 517 0.0420
270 GOUT 748 0.0416
271 NIGHT SWEATS 1339 0.0415
272 NASOPHARYNGITIS 7646 0.0414
273 EXPIRED PRODUCT ADMINISTERED 1375 0.0413
274 INSURANCE ISSUE 631 0.0412
275 WEIGHT FLUCTUATION 428 0.0409
276 MUSCULOSKELETAL CHEST PAIN 633 0.0409
277 PULMONARY HYPERTENSION 851 0.0408
278 ILLNESS 4197 0.0407
279 WALKING AID USER 268 0.0406
280 TROPONIN INCREASED 307 0.0403
281 ORTHOSTATIC HYPOTENSION 702 0.0403
282 OSTEOPOROSIS 1657 0.0402
283 BACTERIAL INFECTION 750 0.0402
284 NODULE 523 0.0400
285 MYASTHENIA GRAVIS 323 0.0400
286 LIGAMENT SPRAIN 394 0.0398
287 LUNG INFILTRATION 350 0.0396
288 IRON DEFICIENCY ANAEMIA 364 0.0394
289 VITAMIN D DEFICIENCY 384 0.0393
290 SLEEP DISORDER 2770 0.0392
291 IMPAIRED GASTRIC EMPTYING 535 0.0392
292 DEVICE DEFECTIVE 678 0.0391
293 HYPOTHYROIDISM 1245 0.0389
294 CONCUSSION 300 0.0387
295 TOOTH ABSCESS 394 0.0387
296 TYPE 2 DIABETES MELLITUS 1298 0.0385
297 PHARYNGOLARYNGEAL PAIN 203 0.0382
298 FRUSTRATION TOLERANCE DECREASED 306 0.0378
299 JOINT INJURY 808 0.0378
300 ECONOMIC PROBLEM 572 0.0377
301 DIVERTICULUM 266 0.0374
302 FLUID RETENTION 1891 0.0371
303 SCIATICA 592 0.0371
304 BLOOD POTASSIUM DECREASED 1110 0.0369
305 VENTRICULAR FIBRILLATION 410 0.0369
306 GASTROENTERITIS VIRAL 666 0.0369
307 GLUCOSE TOLERANCE IMPAIRED 218 0.0368
308 SENSATION OF FOREIGN BODY 310 0.0367
309 OSTEOARTHRITIS 1554 0.0366
310 FACIAL PAIN 326 0.0365
311 SWOLLEN TONGUE 1139 0.0364
312 CHEST PAIN 6741 0.0364
313 RENAL CYST 289 0.0364
314 TENDERNESS 378 0.0362
315 PRODUCT PREPARATION ERROR 745 0.0362
316 DERMATITIS CONTACT 413 0.0362
317 THROAT TIGHTNESS 977 0.0361
318 PHARYNGITIS 448 0.0361
319 LIMB INJURY 978 0.0360
320 MITRAL VALVE INCOMPETENCE 407 0.0359
321 PHARYNGITIS STREPTOCOCCAL 389 0.0359
322 SOMNAMBULISM 235 0.0358
323 JOINT RANGE OF MOTION DECREASED 476 0.0355
324 INCORRECT ROUTE OF PRODUCT ADMINISTRATION 604 0.0352
325 EAR DISCOMFORT 358 0.0348
326 PLEURISY 206 0.0347
327 RETCHING 738 0.0346
328 CORONARY ARTERY DISEASE 1046 0.0345
329 FEELING JITTERY 658 0.0345
330 BLOOD MAGNESIUM DECREASED 297 0.0344
331 POOR VENOUS ACCESS 356 0.0344
332 SUPRAVENTRICULAR TACHYCARDIA 329 0.0343
333 LIVE BIRTH 287 0.0343
334 JOINT DISLOCATION 360 0.0340
335 PANIC REACTION 245 0.0339
336 BACK INJURY 369 0.0339
337 FLANK PAIN 318 0.0339
338 IRRITABLE BOWEL SYNDROME 726 0.0338
339 RESPIRATORY FAILURE 2468 0.0338
340 VITAMIN D DECREASED 289 0.0338
341 ADRENAL INSUFFICIENCY 409 0.0337
342 EYE PRURITUS 1130 0.0336
343 PRODUCT TASTE ABNORMAL 453 0.0334
344 LIP DRY 303 0.0333
345 APPETITE DISORDER 221 0.0333
346 INTERVERTEBRAL DISC PROTRUSION 726 0.0332
347 INFUSION SITE EXTRAVASATION 205 0.0329
348 ARTHROPOD BITE 244 0.0329
349 HELICOBACTER INFECTION 338 0.0329
350 MAJOR DEPRESSION 239 0.0327
351 FOOT DEFORMITY 362 0.0326
352 PRODUCT DOSE OMISSION ISSUE 9593 0.0326
353 ANHEDONIA 853 0.0324
354 WRIST FRACTURE 388 0.0323
355 COVID-19 PNEUMONIA 382 0.0323
356 HAND FRACTURE 228 0.0321
357 PRODUCT STORAGE ERROR 2808 0.0320
358 SINUS TACHYCARDIA 455 0.0320
359 RED BLOOD CELL SEDIMENTATION RATE INCREASED 353 0.0319
360 INITIAL INSOMNIA 327 0.0318
361 BRAIN FOG 499 0.0318
362 ATRIAL FLUTTER 254 0.0318
363 OSTEOPENIA 483 0.0318
364 POOR QUALITY SLEEP 685 0.0318
365 LEFT VENTRICULAR DYSFUNCTION 213 0.0318
366 MYOPATHY 274 0.0317
367 TACHYPNOEA 431 0.0317
368 PANIC ATTACK 1153 0.0316
369 EYE INFECTION 357 0.0316
370 PERIPHERAL SWELLING 4870 0.0316
371 LACRIMATION INCREASED 955 0.0316
372 ANAPHYLACTIC REACTION 1746 0.0316
373 TEMPERATURE INTOLERANCE 325 0.0315
374 MIGRAINE 2998 0.0314
375 NEURALGIA 761 0.0313
376 PERICARDITIS 524 0.0312
377 BLOOD PRESSURE INCREASED 4761 0.0311
378 OEDEMA PERIPHERAL 3786 0.0310
379 CARDIAC FAILURE CONGESTIVE 2494 0.0310
380 DRY MOUTH 2516 0.0310
381 HYPERSENSITIVITY 5753 0.0310
382 PLATELET COUNT INCREASED 404 0.0310
383 BODY HEIGHT DECREASED 331 0.0309
384 HEART RATE IRREGULAR 697 0.0308
385 PULMONARY THROMBOSIS 336 0.0308
386 ATRIAL FIBRILLATION 2999 0.0308
387 NERVE COMPRESSION 284 0.0307
388 ORAL DISORDER 225 0.0307
389 MUSCLE STRAIN 265 0.0306
390 MICTURITION URGENCY 349 0.0305
391 LIP SWELLING 1011 0.0303
392 ECCHYMOSIS 208 0.0303
393 CARDIOGENIC SHOCK 435 0.0303
394 ANXIETY 8626 0.0303
395 NEUTROPHIL COUNT INCREASED 310 0.0302
396 CELLULITIS 1524 0.0302
397 PARAESTHESIA ORAL 436 0.0302
398 BIPOLAR DISORDER 328 0.0301
399 SCRATCH 318 0.0301
400 CYSTITIS 959 0.0301
401 PRODUCT DOSE OMISSION IN ERROR 852 0.0301
402 CONTUSION 2883 0.0299
403 TRANSIENT ISCHAEMIC ATTACK 1010 0.0299
404 CONTRAINDICATED PRODUCT ADMINISTERED 906 0.0299
405 DRUG ADMINISTRATION ERROR 917 0.0298
406 DIZZINESS POSTURAL 289 0.0298
407 HOSPICE CARE 294 0.0297
408 GLOSSODYNIA 666 0.0297
409 PULMONARY OEDEMA 1332 0.0297
410 HYPERTENSION 6294 0.0297
411 BLOOD CHOLESTEROL INCREASED 1383 0.0296
412 DISCOMFORT 1800 0.0295
413 DEVICE USE ISSUE 516 0.0295
414 FOOT FRACTURE 559 0.0295
415 PULMONARY EMBOLISM 2799 0.0294
416 LOWER GASTROINTESTINAL HAEMORRHAGE 216 0.0292
417 RENAL FAILURE CHRONIC 224 0.0291
418 ILL-DEFINED DISORDER 1765 0.0290
419 CATARACT 1721 0.0289
420 PLEURAL EFFUSION 1751 0.0287
421 INTENTIONAL UNDERDOSE 210 0.0287
422 ECZEMA 1503 0.0287
423 MOBILITY DECREASED 2062 0.0287
424 ANKLE FRACTURE 444 0.0287
425 LOWER LIMB FRACTURE 551 0.0286
426 BACK PAIN 6653 0.0286
427 INFECTION 4136 0.0285
428 INTENTIONAL PRODUCT MISUSE 2501 0.0285
429 ARTHRITIS 2247 0.0285
430 PNEUMONITIS 777 0.0285
431 TOOTH INFECTION 376 0.0285
432 BLOOD PRESSURE FLUCTUATION 684 0.0285
433 MUSCULOSKELETAL DISCOMFORT 490 0.0284
434 UNDERDOSE 2078 0.0284
435 ANOSMIA 412 0.0284
436 RESTLESS LEGS SYNDROME 517 0.0284
437 CHOLELITHIASIS 930 0.0283
438 JOINT SWELLING 3423 0.0283
439 DEVICE FAILURE 428 0.0281
440 ROTATOR CUFF SYNDROME 360 0.0280
441 AORTIC ANEURYSM 213 0.0280
442 MOUTH HAEMORRHAGE 205 0.0279
443 HEART RATE DECREASED 978 0.0278
444 DIABETES MELLITUS 2120 0.0278
445 LUPUS-LIKE SYNDROME 252 0.0278
446 COVID-19 4875 0.0278
447 DIVERTICULITIS 767 0.0277
448 URTICARIA 4633 0.0276
449 MEDICATION ERROR 1537 0.0276
450 OEDEMA 1499 0.0276
451 VENTRICULAR EXTRASYSTOLES 287 0.0276
452 WEIGHT DECREASED 7710 0.0276
453 ELECTROCARDIOGRAM ABNORMAL 216 0.0275
454 GLAUCOMA 527 0.0273
455 QUALITY OF LIFE DECREASED 366 0.0273
456 MYOCARDIAL ISCHAEMIA 310 0.0272
457 CHOLECYSTECTOMY 311 0.0272
458 INTENTIONAL DOSE OMISSION 776 0.0272
459 HYSTERECTOMY 235 0.0271
460 INFUSION RELATED REACTION 1785 0.0269
461 ORAL PAIN 603 0.0269
462 DYSURIA 991 0.0269
463 WOUND 751 0.0268
464 PALPITATIONS 3146 0.0268
465 CARDIOMYOPATHY 397 0.0268
466 SWELLING FACE 1746 0.0268
467 SARS-COV-2 TEST POSITIVE 354 0.0268
468 LOCALISED INFECTION 645 0.0266
469 GALLBLADDER DISORDER 476 0.0266
470 RENAL INJURY 792 0.0266
471 HEREDITARY ANGIOEDEMA 286 0.0266
472 HYPOMAGNESAEMIA 371 0.0266
473 CYANOSIS 419 0.0266
474 HEPATIC CIRRHOSIS 500 0.0266
475 KIDNEY INFECTION 521 0.0265
476 UPPER LIMB FRACTURE 528 0.0265
477 DENTAL CARIES 292 0.0264
478 PRODUCT DOSE OMISSION 1720 0.0263
479 HYPOKALAEMIA 1212 0.0262
480 BLOOD PRESSURE ABNORMAL 522 0.0262
481 ROAD TRAFFIC ACCIDENT 1097 0.0262
482 AFFECTIVE DISORDER 206 0.0262
483 NECK PAIN 1459 0.0261
484 BLOOD SODIUM DECREASED 492 0.0261
485 MALNUTRITION 292 0.0261
486 PRODUCT DISTRIBUTION ISSUE 242 0.0261
487 MALAISE 11441 0.0261
488 INCREASED TENDENCY TO BRUISE 240 0.0261
489 BACK DISORDER 424 0.0261
490 DEPRESSION 5925 0.0260
491 TENDONITIS 403 0.0260
492 PERICARDIAL EFFUSION 601 0.0260
493 APNOEA 202 0.0259
494 CONJUNCTIVITIS 481 0.0259
495 TACHYCARDIA 2303 0.0259
496 PRODUCT USE IN UNAPPROVED INDICATION 6415 0.0259
497 RASH ERYTHEMATOUS 1237 0.0258
498 WHITE BLOOD CELL COUNT INCREASED 990 0.0258
499 FUNGAL INFECTION 859 0.0257
500 DYSPEPSIA 2531 0.0257
501 HEADACHE 16065 0.0256
502 NOCTURIA 311 0.0256
503 LUNG NEOPLASM MALIGNANT 1053 0.0256
504 INABILITY TO AFFORD MEDICATION 254 0.0256
505 UPPER GASTROINTESTINAL HAEMORRHAGE 430 0.0255
506 PHARYNGEAL OEDEMA 393 0.0255
507 TOOTH FRACTURE 280 0.0254
508 TREMOR 4207 0.0253
509 VENTRICULAR TACHYCARDIA 418 0.0253
510 INJURY 1776 0.0252
511 DRUG INTOLERANCE 2438 0.0252
512 EPISTAXIS 1885 0.0252
513 POST PROCEDURAL INFECTION 204 0.0251
514 SKIN LESION 688 0.0251
515 SWELLING 2347 0.0251
516 NEPHROLITHIASIS 1149 0.0250
517 SEDATION 656 0.0250
518 OBSESSIVE-COMPULSIVE DISORDER 201 0.0250
519 CONSTIPATION 5460 0.0250
520 INSOMNIA 6666 0.0250
521 WEIGHT INCREASED 5604 0.0250
522 HAEMATOCRIT DECREASED 496 0.0250
523 HEPATIC STEATOSIS 464 0.0249
524 NERVOUSNESS 1301 0.0249
525 RENAL TUBULAR NECROSIS 244 0.0248
526 HOSPITALISATION 3822 0.0248
527 CONDITION AGGRAVATED 7553 0.0248
528 GASTROENTERITIS 361 0.0247
529 SPINAL FRACTURE 495 0.0247
530 BLISTER 1386 0.0247
531 DECUBITUS ULCER 201 0.0246
532 ULCER 392 0.0246
533 RENAL FAILURE 3269 0.0246
534 DEVICE ISSUE 2197 0.0245
535 ORAL HERPES 478 0.0245
536 ASCITES 719 0.0244
537 FALL 8139 0.0244
538 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 4405 0.0244
539 URINARY TRACT INFECTION 4168 0.0244
540 CYST 303 0.0244
541 ASTHENIA 9166 0.0244
542 MUSCLE SPASMS 4473 0.0244
543 NEPHROPATHY 227 0.0243
544 SPINAL COMPRESSION FRACTURE 201 0.0243
545 HERNIA 470 0.0243
546 ANGIOEDEMA 1073 0.0242
547 HEPATIC ENZYME INCREASED 1649 0.0242
548 SKIN INFECTION 271 0.0241
549 ANGINA PECTORIS 692 0.0241
550 ACUTE KIDNEY INJURY 3695 0.0241
551 COGNITIVE DISORDER 1127 0.0241
552 HAEMORRHOIDS 469 0.0240
553 IMPAIRED HEALING 788 0.0240
554 BALANCE DISORDER 2073 0.0240
555 STAPHYLOCOCCAL INFECTION 791 0.0240
556 ABDOMINAL PAIN UPPER 4935 0.0239
557 MACULAR DEGENERATION 286 0.0239
558 ELECTROLYTE IMBALANCE 277 0.0238
559 DIABETES MELLITUS INADEQUATE CONTROL 422 0.0238
560 PAIN IN JAW 675 0.0238
561 PYELONEPHRITIS 206 0.0237
562 RECTAL HAEMORRHAGE 1021 0.0237
563 ORAL DISCOMFORT 330 0.0237
564 DISABILITY 469 0.0237
565 ABDOMINAL PAIN 5512 0.0237
566 JOINT STIFFNESS 621 0.0236
567 BLADDER DISORDER 235 0.0236
568 TASTE DISORDER 480 0.0236
569 CARDIAC DISORDER 2211 0.0236
570 MUSCULOSKELETAL PAIN 1234 0.0235
571 PRODUCT USE ISSUE 4423 0.0235
572 GASTRITIS 619 0.0235
573 THROMBOSIS 1884 0.0234
574 TREATMENT NONCOMPLIANCE 1281 0.0234
575 HYPERSOMNIA 671 0.0234
576 HYPERHIDROSIS 3015 0.0234
577 FREQUENT BOWEL MOVEMENTS 632 0.0234
578 PYREXIA 8072 0.0233
579 GAIT INABILITY 779 0.0233
580 PRODUCT USE COMPLAINT 367 0.0233
581 CLOSTRIDIUM DIFFICILE COLITIS 247 0.0233
582 TOOTHACHE 420 0.0232
583 BLOOD PRESSURE DECREASED 1540 0.0232
584 AMNESIA 1507 0.0231
585 OCULAR DISCOMFORT 260 0.0231
586 ANAL INCONTINENCE 208 0.0231
587 POST PROCEDURAL COMPLICATION 444 0.0231
588 PULMONARY ARTERIAL HYPERTENSION 335 0.0231
589 DEPRESSED MOOD 1222 0.0231
590 HYPONATRAEMIA 1302 0.0231
591 FEELING COLD 643 0.0231
592 MUSCULAR WEAKNESS 2624 0.0231
593 ABDOMINAL DISTENSION 2409 0.0231
594 PRESYNCOPE 561 0.0231
595 OESOPHAGITIS 252 0.0230
596 SKIN FISSURES 450 0.0230
597 GROIN PAIN 202 0.0230
598 GASTROINTESTINAL DISORDER 2060 0.0230
599 BURNING SENSATION 1610 0.0229
600 LIVER FUNCTION TEST INCREASED 492 0.0229
601 EYE DISCHARGE 238 0.0229
602 HEAD INJURY 724 0.0229
603 GENERALISED OEDEMA 283 0.0228
604 EXPOSURE VIA SKIN CONTACT 591 0.0228
605 DEEP VEIN THROMBOSIS 1481 0.0228
606 PAIN IN EXTREMITY 6707 0.0227
607 HYPOAESTHESIA ORAL 343 0.0227
608 BRAIN INJURY 228 0.0227
609 HAND DEFORMITY 298 0.0227
610 HEAD DISCOMFORT 402 0.0227
611 MASS 317 0.0227
612 RESPIRATORY DEPRESSION 278 0.0227
613 SMALL INTESTINAL OBSTRUCTION 279 0.0226
614 DYSPHAGIA 2146 0.0226
615 SCAR 385 0.0225
616 EXPOSURE DURING PREGNANCY 1396 0.0224
617 URINARY INCONTINENCE 665 0.0224
618 TRANSFUSION 234 0.0223
619 DRY EYE 1114 0.0223
620 MENTAL STATUS CHANGES 619 0.0223
621 FEEDING DISORDER 452 0.0223
622 SPINAL OPERATION 274 0.0222
623 CIRCUMSTANCE OR INFORMATION CAPABLE OF LEADING TO MEDICATION ERROR 751 0.0222
624 BLOOD URINE PRESENT 422 0.0222
625 FLUID OVERLOAD 323 0.0222
626 NIGHTMARE 767 0.0221
627 IMMUNE SYSTEM DISORDER 292 0.0221
628 HYPOTENSION 4443 0.0221
629 HYPERGLYCAEMIA 807 0.0221
630 CHILLS 2595 0.0221
631 FATIGUE 17203 0.0221
632 LYMPHADENOPATHY 780 0.0220
633 EYE PAIN 1241 0.0220
634 BLOOD UREA INCREASED 368 0.0220
635 BONE DISORDER 400 0.0219
636 LEUKOCYTOSIS 397 0.0219
637 EYE SWELLING 816 0.0219
638 DIZZINESS 10932 0.0219
639 THERAPEUTIC RESPONSE SHORTENED 726 0.0219
640 INTENTIONAL PRODUCT USE ISSUE 1917 0.0219
641 PNEUMONIA ASPIRATION 544 0.0218
642 HYPOKINESIA 316 0.0217
643 DIPLOPIA 565 0.0217
644 FEELING HOT 1332 0.0217
645 ACCIDENT 259 0.0217
646 THYROID DISORDER 334 0.0216
647 RENAL DISORDER 1009 0.0216
648 HIP ARTHROPLASTY 331 0.0216
649 INFLAMMATION 1114 0.0216
650 HERPES ZOSTER 1240 0.0216
651 DEHYDRATION 2865 0.0215
652 GENERAL PHYSICAL HEALTH DETERIORATION 2485 0.0215
653 PAIN 13186 0.0214
654 PARANOIA 370 0.0214
655 SEPSIS 2388 0.0214
656 GAIT DISTURBANCE 4086 0.0213
657 COAGULOPATHY 355 0.0213
658 STOMATITIS 1292 0.0213
659 MEMORY IMPAIRMENT 2926 0.0213
660 EYE DISORDER 698 0.0212
661 COLD SWEAT 374 0.0212
662 TINNITUS 974 0.0212
663 PHOTOPHOBIA 398 0.0211
664 DELIRIUM 734 0.0211
665 RENAL PAIN 224 0.0211
666 ARTHRALGIA 8785 0.0211
667 OVARIAN CYST 211 0.0211
668 DRUG DOSE OMISSION 3489 0.0211
669 PSYCHOMOTOR HYPERACTIVITY 350 0.0211
670 MUSCLE TIGHTNESS 341 0.0210
671 CLOSTRIDIUM DIFFICILE INFECTION 459 0.0210
672 HYPOACUSIS 905 0.0210
673 VOMITING 9875 0.0210
674 CHOLECYSTITIS 250 0.0210
675 THERAPY NON-RESPONDER 940 0.0209
676 SPEECH DISORDER 1095 0.0209
677 ABSCESS 333 0.0209
678 AGEUSIA 520 0.0208
679 SYNOVITIS 375 0.0208
680 HYPOAESTHESIA 3108 0.0207
681 POLLAKIURIA 866 0.0207
682 RASH PRURITIC 1124 0.0207
683 URINARY RETENTION 691 0.0207
684 THERAPEUTIC RESPONSE DECREASED 1255 0.0207
685 PRODUCT SUBSTITUTION ISSUE 1187 0.0206
686 ABDOMINAL DISCOMFORT 3457 0.0206
687 DERMATITIS ATOPIC 1085 0.0206
688 DEPRESSED LEVEL OF CONSCIOUSNESS 813 0.0205
689 ARTHROPATHY 1141 0.0205
690 DECREASED APPETITE 4763 0.0205
691 MYALGIA 3486 0.0205
692 LIMB DISCOMFORT 633 0.0204
693 MUSCULOSKELETAL STIFFNESS 1790 0.0204
694 AGGRESSION 1018 0.0203
695 INFLUENZA LIKE ILLNESS 1667 0.0202
696 CORONARY ARTERY OCCLUSION 277 0.0202
697 SKIN HAEMORRHAGE 299 0.0202
698 MOUTH ULCERATION 425 0.0201
699 LETHARGY 1157 0.0201
700 PRURITUS 7726 0.0201
701 HALLUCINATION 1514 0.0201
702 ANGER 677 0.0200
703 BLOOD POTASSIUM INCREASED 325 0.0200
704 FEELING ABNORMAL 4788 0.0200
705 TOOTH DISORDER 444 0.0199
706 SKIN ULCER 515 0.0199
707 HYPERKALAEMIA 698 0.0199
708 KNEE ARTHROPLASTY 419 0.0199
709 HAEMATURIA 681 0.0199
710 HAEMATEMESIS 503 0.0198
711 RED BLOOD CELL COUNT DECREASED 566 0.0198
712 DRUG EFFECT LESS THAN EXPECTED 293 0.0198
713 MUSCLE TWITCHING 455 0.0197
714 INCREASED APPETITE 377 0.0197
715 SCAB 225 0.0197
716 SYNCOPE 1968 0.0196
717 FEAR 528 0.0196
718 SURGERY 1150 0.0196
719 PROCEDURAL PAIN 543 0.0196
720 LACTIC ACIDOSIS 633 0.0195
721 RASH MACULAR 683 0.0195
722 MENTAL DISORDER 841 0.0193
723 RASH 8404 0.0193
724 VISION BLURRED 2643 0.0192
725 PEMPHIGUS 240 0.0192
726 HAEMOGLOBIN DECREASED 1970 0.0192
727 INTERNAL HAEMORRHAGE 219 0.0191
728 DIARRHOEA 12361 0.0191
729 HAEMATOMA 494 0.0190
730 PRODUCT PRESCRIBING ERROR 454 0.0190
731 MULTIPLE ORGAN DYSFUNCTION SYNDROME 539 0.0190
732 PERIPHERAL COLDNESS 261 0.0190
733 FAECES DISCOLOURED 412 0.0190
734 PARAESTHESIA 2984 0.0189
735 FLATULENCE 1075 0.0189
736 NAUSEA 14984 0.0189
737 BLOOD CREATININE INCREASED 1232 0.0189
738 THERAPY INTERRUPTED 1348 0.0188
739 CRYING 684 0.0188
740 CONFUSIONAL STATE 3039 0.0188
741 PRODUCT PHYSICAL ISSUE 379 0.0188
742 THIRST 335 0.0187
743 BONE PAIN 1098 0.0187
744 EXTRA DOSE ADMINISTERED 759 0.0187
745 INTERNATIONAL NORMALISED RATIO INCREASED 534 0.0187
746 SKIN DISCOLOURATION 860 0.0187
747 EJECTION FRACTION DECREASED 289 0.0186
748 PALLOR 505 0.0185
749 DEMENTIA 518 0.0185
750 DYSGEUSIA 1377 0.0185
751 RHEUMATOID ARTHRITIS 2099 0.0185
752 VERTIGO 1126 0.0185
753 DISTURBANCE IN ATTENTION 996 0.0184
754 TENDON RUPTURE 228 0.0184
755 TUBULOINTERSTITIAL NEPHRITIS 345 0.0184
756 EATING DISORDER 389 0.0183
757 ILEUS 227 0.0182
758 LOSS OF CONSCIOUSNESS 2321 0.0181
759 DYSARTHRIA 681 0.0181
760 MUSCLE ATROPHY 229 0.0181
761 RENAL FAILURE ACUTE 764 0.0180
762 PELVIC PAIN 327 0.0180
763 RESPIRATORY ARREST 496 0.0180
764 PHOTOSENSITIVITY REACTION 297 0.0180
765 VISUAL IMPAIRMENT 2224 0.0179
766 INTESTINAL OBSTRUCTION 675 0.0179
767 GASTROINTESTINAL HAEMORRHAGE 1490 0.0178
768 PSORIATIC ARTHROPATHY 721 0.0177
769 SPLENOMEGALY 208 0.0177
770 MOOD ALTERED 484 0.0177
771 DRUG INEFFECTIVE 23357 0.0177
772 UNRESPONSIVE TO STIMULI 457 0.0177
773 SYSTEMIC LUPUS ERYTHEMATOSUS 628 0.0177
774 HIP FRACTURE 569 0.0177
775 OCULAR HYPERAEMIA 839 0.0177
776 SUICIDAL IDEATION 1617 0.0176
777 ABNORMAL DREAMS 487 0.0176
778 NEUROPATHY PERIPHERAL 1677 0.0176
779 MOVEMENT DISORDER 566 0.0176
780 HAIR COLOUR CHANGES 219 0.0176
781 HOT FLUSH 1325 0.0176
782 BLOOD ALKALINE PHOSPHATASE INCREASED 436 0.0175
783 ANAEMIA 3348 0.0175
784 MOOD SWINGS 559 0.0175
785 PRODUCT ADMINISTRATION ERROR 354 0.0175
786 PRODUCT AVAILABILITY ISSUE 398 0.0175
787 PANCREATITIS 923 0.0174
788 ACUTE MYOCARDIAL INFARCTION 514 0.0174
789 C-REACTIVE PROTEIN INCREASED 631 0.0173
790 LYMPHOCYTE COUNT DECREASED 306 0.0173
791 BLOOD BILIRUBIN INCREASED 467 0.0173
792 OSTEOMYELITIS 313 0.0173
793 LIVER DISORDER 765 0.0172
794 GLOMERULAR FILTRATION RATE DECREASED 210 0.0171
795 AGITATION 1253 0.0170
796 THERAPEUTIC PRODUCT EFFECT DECREASED 764 0.0170
797 TOOTH EXTRACTION 212 0.0170
798 BASAL CELL CARCINOMA 265 0.0170
799 LABORATORY TEST ABNORMAL 501 0.0170
800 PRURITUS GENERALISED 367 0.0170
801 DYSSTASIA 495 0.0169
802 ABNORMAL BEHAVIOUR 671 0.0169
803 SOMNOLENCE 3410 0.0169
804 HYPOPHAGIA 431 0.0168
805 SCHIZOPHRENIA 204 0.0168
806 HYPOGLYCAEMIA 809 0.0167
807 FACE OEDEMA 281 0.0166
808 FULL BLOOD COUNT DECREASED 335 0.0166
809 CHROMATURIA 375 0.0166
810 GASTRIC ULCER 314 0.0165
811 HAEMATOCHEZIA 908 0.0164
812 INCORRECT DOSE ADMINISTERED 3747 0.0164
813 SKIN EXFOLIATION 1379 0.0163
814 ERYTHEMA 3350 0.0163
815 SKIN DISORDER 543 0.0163
816 MYOCARDIAL INFARCTION 2830 0.0162
817 DEVICE BREAKAGE 656 0.0161
818 CARDIAC FAILURE 1296 0.0161
819 BEDRIDDEN 212 0.0161
820 DERMATITIS ALLERGIC 202 0.0160
821 OFF LABEL USE 14014 0.0160
822 HAIR TEXTURE ABNORMAL 214 0.0160
823 IRRITABILITY 961 0.0160
824 EYE IRRITATION 917 0.0159
825 ARRHYTHMIA 753 0.0159
826 EMOTIONAL DISTRESS 1924 0.0159
827 ANAPHYLACTIC SHOCK 409 0.0158
828 DEVICE RELATED INFECTION 242 0.0157
829 APHASIA 474 0.0157
830 PREGNANCY 314 0.0157
831 SENSORY DISTURBANCE 251 0.0156
832 THERAPEUTIC RESPONSE UNEXPECTED 701 0.0156
833 ACTIVITIES OF DAILY LIVING IMPAIRED 309 0.0156
834 LOCAL SWELLING 271 0.0155
835 ADVERSE DRUG REACTION 1394 0.0155
836 COMPLICATION ASSOCIATED WITH DEVICE 225 0.0155
837 TRANSAMINASES INCREASED 344 0.0155
838 DRY SKIN 2063 0.0154
839 DISEASE RECURRENCE 735 0.0154
840 MELAENA 340 0.0154
841 HYPERTHYROIDISM 223 0.0154
842 EMOTIONAL DISORDER 473 0.0153
843 LIVER FUNCTION TEST ABNORMAL 446 0.0153
844 HALLUCINATION, AUDITORY 242 0.0152
845 FLUSHING 1539 0.0151
846 LIVER INJURY 371 0.0151
847 RESTLESSNESS 552 0.0151
848 METABOLIC ACIDOSIS 480 0.0150
849 PARALYSIS 214 0.0149
850 HALLUCINATION, VISUAL 315 0.0149
851 SEIZURE 1719 0.0149
852 IMPAIRED WORK ABILITY 318 0.0149
853 HEMIPARESIS 251 0.0148
854 THINKING ABNORMAL 275 0.0147
855 DRUG DISPENSING ERROR 225 0.0147
856 UNEVALUABLE EVENT 1113 0.0147
857 ADVERSE EVENT 1352 0.0147
858 GASTRIC DISORDER 503 0.0146
859 DEAFNESS 383 0.0146
860 THERAPY CESSATION 751 0.0146
861 BLOOD TRIGLYCERIDES INCREASED 258 0.0146
862 PRODUCT PRESCRIBING ISSUE 318 0.0146
863 DERMATITIS 305 0.0145
864 DISORIENTATION 576 0.0145
865 COLITIS 550 0.0145
866 HUNGER 201 0.0144
867 CARDIAC ARREST 1191 0.0144
868 BLINDNESS 587 0.0144
869 ABDOMINAL PAIN LOWER 363 0.0143
870 INJECTION SITE URTICARIA 349 0.0142
871 INJECTION SITE SWELLING 1086 0.0142
872 HYPOCALCAEMIA 268 0.0141
873 ASPARTATE AMINOTRANSFERASE INCREASED 752 0.0141
874 COLITIS ULCERATIVE 630 0.0141
875 ERUCTATION 272 0.0140
876 DYSKINESIA 571 0.0140
877 PSYCHOTIC DISORDER 413 0.0140
878 RASH PAPULAR 312 0.0139
879 CIRCULATORY COLLAPSE 237 0.0139
880 CEREBROVASCULAR ACCIDENT 2346 0.0138
881 MENTAL IMPAIRMENT 335 0.0138
882 BRADYCARDIA 730 0.0137
883 MATERNAL EXPOSURE DURING PREGNANCY 1225 0.0137
884 PRESCRIBED UNDERDOSE 274 0.0137
885 PANCREATITIS ACUTE 306 0.0136
886 TOOTH LOSS 281 0.0135
887 THROMBOCYTOPENIA 1513 0.0135
888 SEPTIC SHOCK 586 0.0135
889 INJECTION SITE RASH 413 0.0134
890 ACUTE RESPIRATORY DISTRESS SYNDROME 236 0.0133
891 MULTIPLE FRACTURES 217 0.0132
892 ALOPECIA 2585 0.0131
893 ELECTROCARDIOGRAM QT PROLONGED 472 0.0131
894 ALANINE AMINOTRANSFERASE INCREASED 802 0.0130
895 INJECTION SITE PRURITUS 867 0.0129
896 DRUG INEFFECTIVE FOR UNAPPROVED INDICATION 710 0.0129
897 DRUG EFFECT DECREASED 696 0.0129
898 RENAL IMPAIRMENT 1069 0.0127
899 PSORIASIS 1646 0.0126
900 BONE DENSITY DECREASED 394 0.0126
901 DRUG INTERACTION 1994 0.0126
902 ENCEPHALOPATHY 308 0.0125
903 BLOOD GLUCOSE DECREASED 600 0.0125
904 ABASIA 307 0.0124
905 PRODUCT DISPENSING ERROR 267 0.0122
906 PAIN OF SKIN 330 0.0122
907 INJECTION SITE BRUISING 977 0.0122
908 INJECTION SITE PAIN 3755 0.0122
909 INTERSTITIAL LUNG DISEASE 588 0.0121
910 SKIN CANCER 261 0.0121
911 FEBRILE NEUTROPENIA 792 0.0119
912 MUSCULOSKELETAL DISORDER 227 0.0119
913 DEVICE LEAKAGE 517 0.0119
914 BLOOD CREATINE PHOSPHOKINASE INCREASED 343 0.0119
915 INTENTIONAL DRUG MISUSE 249 0.0119
916 HAEMORRHAGE 1238 0.0118
917 NEOPLASM MALIGNANT 790 0.0118
918 OVERDOSE 2541 0.0118
919 DRUG EXPOSURE DURING PREGNANCY 398 0.0117
920 BLOOD GLUCOSE ABNORMAL 216 0.0117
921 HEPATIC FAILURE 350 0.0116
922 FRACTURE 219 0.0116
923 PLATELET COUNT DECREASED 1215 0.0114
924 CARDIO-RESPIRATORY ARREST 475 0.0113
925 VISUAL ACUITY REDUCED 374 0.0112
926 INJECTION SITE ERYTHEMA 1367 0.0110
927 DRUG EFFECT INCOMPLETE 398 0.0109
928 CONVULSION 624 0.0109
929 NERVOUS SYSTEM DISORDER 337 0.0108
930 FEMUR FRACTURE 334 0.0108
931 TREATMENT FAILURE 888 0.0107
932 PLASMA CELL MYELOMA 407 0.0104
933 INJECTION SITE MASS 385 0.0104
934 DIABETIC KETOACIDOSIS 250 0.0104
935 COMA 493 0.0103
936 CARDIOVASCULAR DISORDER 262 0.0103
937 WHITE BLOOD CELL COUNT DECREASED 1112 0.0102
938 RASH GENERALISED 265 0.0102
939 ACCIDENTAL OVERDOSE 372 0.0102
940 GLYCOSYLATED HAEMOGLOBIN INCREASED 256 0.0101
941 RHABDOMYOLYSIS 423 0.0101
942 EPILEPSY 308 0.0101
943 INJECTION SITE WARMTH 207 0.0101
944 GAMMA-GLUTAMYLTRANSFERASE INCREASED 223 0.0101
945 BLOOD GLUCOSE INCREASED 1886 0.0100
946 STEVENS-JOHNSON SYNDROME 222 0.0100
947 NEEDLE ISSUE 289 0.0099
948 ACCIDENTAL EXPOSURE TO PRODUCT 1015 0.0098
949 HEPATITIS 252 0.0098
950 INJECTION SITE REACTION 677 0.0098
951 INCORRECT PRODUCT ADMINISTRATION DURATION 212 0.0098
952 PANCYTOPENIA 546 0.0098
953 OSTEONECROSIS 318 0.0097
954 RASH MACULO-PAPULAR 210 0.0094
955 SHOCK 214 0.0093
956 DEATH 7988 0.0093
957 INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION 659 0.0093
958 DEVICE DISLOCATION 402 0.0092
959 HEPATOTOXICITY 203 0.0091
960 PREMATURE BABY 273 0.0091
961 JAUNDICE 244 0.0091
962 MUCOSAL INFLAMMATION 237 0.0090
963 DRUG-INDUCED LIVER INJURY 283 0.0090
964 INCORRECT ROUTE OF DRUG ADMINISTRATION 322 0.0090
965 NEUTROPHIL COUNT DECREASED 360 0.0088
966 SUICIDE ATTEMPT 533 0.0088
967 DISEASE PROGRESSION 1039 0.0088
968 OSTEONECROSIS OF JAW 217 0.0088
969 MULTIPLE SCLEROSIS 412 0.0086
970 ERECTILE DYSFUNCTION 219 0.0085
971 LEUKOPENIA 423 0.0084
972 ABORTION SPONTANEOUS 338 0.0084
973 WITHDRAWAL SYNDROME 342 0.0081
974 VAGINAL HAEMORRHAGE 345 0.0079
975 WRONG TECHNIQUE IN DRUG USAGE PROCESS 288 0.0079
976 CEREBRAL HAEMORRHAGE 278 0.0078
977 TARDIVE DYSKINESIA 217 0.0077
978 INTENTIONAL OVERDOSE 484 0.0075
979 ACNE 572 0.0075
980 MULTIPLE SCLEROSIS RELAPSE 516 0.0075
981 SKIN IRRITATION 343 0.0075
982 TOXICITY TO VARIOUS AGENTS 1247 0.0074
983 INJECTION SITE HAEMORRHAGE 587 0.0073
984 NEUTROPENIA 977 0.0072
985 FOETAL EXPOSURE DURING PREGNANCY 547 0.0067
986 DEVICE DIFFICULT TO USE 433 0.0065
987 SKIN BURNING SENSATION 458 0.0064
988 MALIGNANT NEOPLASM PROGRESSION 575 0.0056
989 BREAST CANCER 502 0.0054
990 DRUG ABUSE 448 0.0054
991 DRUG DEPENDENCE 861 0.0053
992 DRUG WITHDRAWAL SYNDROME 456 0.0052
993 PROSTATE CANCER 346 0.0043